Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Completed"
topic_facet:"Medical Condition: Healthy"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Healthy%22&lookfor=%22610%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Healthy%22&lookfor=%22610%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Healthy%22&lookfor=%22610%22&type=Subject
PubPharm (5.861)
1
Investigation of Safety, Tolerability, Immunogenicity and Pharmacokinetics of Single-Dose of PF-06823859 in Japanese Healthy Participants : A PHASE 1, RANDOMIZED, DOUBLE BLIND, SPONSOR-OPEN, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETICS FOLLOWING SINGLE INTRAVENOUS DOSE OF PF-06823859 IN JAPANESE HEALTHY PARTICIPANTS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Investigation of Safety, Tolerability, Immunogenicity and Pharmacokinetics of Single-Dose of PF-06823859 in Japanese Healthy Participants : A PHASE 1, RANDOMIZED, DOUBLE BLIND, SPONSOR-OPEN, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETICS FOLLOWING SINGLE INTRAVENOUS DOSE OF PF-06823859 IN JAPANESE HEALTHY PARTICIPANTS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Study of ALXN1820 in Healthy Adult Participants : A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Study of Subcutaneous and Intravenous ALXN1820 in Healthy Participants
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
4
Cybersickness imAgiNg Olfactory Evocation : Cybersickness imAgiNg Olfactory Evocation
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
5
Pharmacokinetics, Safety, and Tolerability of Various XW10172 Oral Formulations in Healthy Adult Volunteers : An Open-label, Crossover Study to Assess the Pharmacokinetics, Safety, and Tolerability of Various XW10172 Oral Immediate- and Modified-release Formulations in Healthy Adult Volunteers
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
6
A Pilot Study of the Safety, Tolerability, and Effectiveness of Halo : A Pilot Study of the Safety, Tolerability, and Effectiveness of Halo to Prevent Acute Upper Respiratory Disease and Respiratory Virus Infections
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
7
PK and PD Crossover Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant Epoetin and Eprex, in Healthy Subjects. : Phase 1 Assessment of Pharmacokinetics and Pharmacodynamics of Two Epoetin Alfa, Human Recombinant Epoetin (Blau Farmacêutica) and Eprex (Janssen-Cilag), After Single Dose, Intravenous Administration in Healthy Subjects: a Randomized Crossover Study.
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
8
Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose : Pharmacodynamics Study of Enoxalow, Produced by Blau Farmacêutica S/A, Compared to Clexane, Produced by Sanofi-Aventis Farmacêutica Ltda, in Healthy Subjects After Subcutaneous Administration.
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
9
Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous Administration : Pharmacodynamics Study of Enoxalow, Produced by Blau Farmacêutica S/A, Compared to Clexane, Produced by Sanofi-Aventis Farmacêutica Ltda, in Healthy Subjects After Intravenous Administration.
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
10
PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant : Phase 1 Assessment of Pharmacokinetics and Pharmacodynamics of Two Epoetin Alfa, Human Recombinant Epoetin (Blau Farmacêutica) and Eprex (Janssen-Cilag), After Multiple Dose, Intravenous Administration in Healthy Subjects: a Randomized Parallel Study.
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[587]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Recruitment Status: Completed
Filter aufheben
Thema: Medical Condition: Healthy
Medienart
5.861
Aufsätze
5.861
E-Artikel
5.861
E-Ressourcen
Zeitschriftentitel
5.849
ClinicalTrials.gov
12
WHO International Clinical Trials Registry Plat...
Thema
5.861
610
Medical Condition: Healthy
Recruitment Status: Completed
5.532
Study Type: Interventional
3.848
Phase: Phase 1
326
Study Type: Observational
156
Phase: Phase 4
149
Malnutrition
67
Phase: Phase 2
64
Phase: Phase 3
60
Phase: Early Phase 1
49
Phase: Phase 1/Phase 2
34
Disease
26
Respiratory Aspiration
15
Influenza, Human
14
Tissue Adhesions
12
Phase: Phase 2/Phase 3
10
Inflammation
9
Overweight
7
Fatigue
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.148
2020-
4.067
2010-2019
646
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
5.861
Englisch
Haven't found what you're looking for?
Wird geladen...